NCT00804440View on ClinicalTrials.gov

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2004

Conditions
Bioequivalency
Interventions
DRUG

Ibuprofen Tablets, 800 mg

All Listed Sponsors
lead

Perrigo Company

INDUSTRY

NCT00804440 - Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter